Oxulumis®, Suprachoroidal Drug Administration of Triesence® in Diabetic Macular Edema

Clinical trial NCT05172401 · WITHDRAWN

Trial details

NCT number: NCT05172401
Sponsor: Oxular Limited
Status: WITHDRAWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Diabetic Macular Edema

Start date: 2022-09-15
Primary completion: 2023-01-31
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.